Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Downgrades Trimble to Neutral, Lowers Price Target to $70

Piper Sandler analyst Clarke Jeffries downgrades Trimble (NASDAQ:TRMB) from Overweight to Neutral and lowers the price target from $82 to $70.
byBenzinga Newsdesk
September 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Piper Sandler analyst Clarke Jeffries downgrades Trimble (NASDAQ:TRMB) from Overweight to Neutral and lowers the price target from $82 to $70.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio

By Vandana Singh
August 1, 8:30 AM
Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of its overarching strategy to strengthen its IP portfolio further.

CMND